The synthesis of group 9 complexes for use as transfer hydrogenation catalysts and anti-cancer agents

This thesis concerns the synthesis of group 9 Cp* and hydroxyl tethered Cp* based complexes for their use as both anti-cancer agents and transfer hydrogenation catalysts. The successful catalysts were immobilised covalently onto Wang resin for their use as recyclable transfer hydrogenation catalysts...

Full description

Bibliographic Details
Main Author: Lucas, Stephanie Jayne
Published: University of Leeds 2013
Subjects:
547
Online Access:http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.581646
id ndltd-bl.uk-oai-ethos.bl.uk-581646
record_format oai_dc
spelling ndltd-bl.uk-oai-ethos.bl.uk-5816462018-06-06T15:38:51ZThe synthesis of group 9 complexes for use as transfer hydrogenation catalysts and anti-cancer agentsLucas, Stephanie Jayne2013This thesis concerns the synthesis of group 9 Cp* and hydroxyl tethered Cp* based complexes for their use as both anti-cancer agents and transfer hydrogenation catalysts. The successful catalysts were immobilised covalently onto Wang resin for their use as recyclable transfer hydrogenation catalysts in the reduction of benzaldehyde and acetophenone. Chapter 1 is a current review of transfer hydrogenation using metal-arene complexes and immobilised catalysts. Chapter 2 describes the synthesis and characterisation of group 9 hydroxyl tethered Cp* based dihalide dimers. Chapter 3 describes the synthesis and characterisation of group 9 Cp* and hydroxyl tethered Cp* based pyridine dihalide complexes. Chapter 4 describes the syntheseis and characterisation of group 9 Cp* and hydroxyl tethered Cp* based picolinamide halide complexes. Chapter 5 describes the synthesis and characterisation of iridium Cp* chloride bidentate complexes, where the bidentate ligand is either an XL or 2L ligand. Chapter 6 describes the catalytic testing of compounds discussed in Chapters 2-5 for the reduction of benzaldehyde and acetophenone. Chapter 7 describes the synthesis and characterisation and catalytic activity of immobilised group 9 hydroxyl tethered Cp* based dichloride dimers. Chapter 8 describes in vitro IC50 results for select compounds described in Chapters 2-5 against a range of cancer cell lines. Chapter 9 gives experimental details for processes discussed in Chapters 2-8 and characterisation data for the novel compounds discussed in Chapters 2-5.547University of Leedshttp://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.581646http://etheses.whiterose.ac.uk/4441/Electronic Thesis or Dissertation
collection NDLTD
sources NDLTD
topic 547
spellingShingle 547
Lucas, Stephanie Jayne
The synthesis of group 9 complexes for use as transfer hydrogenation catalysts and anti-cancer agents
description This thesis concerns the synthesis of group 9 Cp* and hydroxyl tethered Cp* based complexes for their use as both anti-cancer agents and transfer hydrogenation catalysts. The successful catalysts were immobilised covalently onto Wang resin for their use as recyclable transfer hydrogenation catalysts in the reduction of benzaldehyde and acetophenone. Chapter 1 is a current review of transfer hydrogenation using metal-arene complexes and immobilised catalysts. Chapter 2 describes the synthesis and characterisation of group 9 hydroxyl tethered Cp* based dihalide dimers. Chapter 3 describes the synthesis and characterisation of group 9 Cp* and hydroxyl tethered Cp* based pyridine dihalide complexes. Chapter 4 describes the syntheseis and characterisation of group 9 Cp* and hydroxyl tethered Cp* based picolinamide halide complexes. Chapter 5 describes the synthesis and characterisation of iridium Cp* chloride bidentate complexes, where the bidentate ligand is either an XL or 2L ligand. Chapter 6 describes the catalytic testing of compounds discussed in Chapters 2-5 for the reduction of benzaldehyde and acetophenone. Chapter 7 describes the synthesis and characterisation and catalytic activity of immobilised group 9 hydroxyl tethered Cp* based dichloride dimers. Chapter 8 describes in vitro IC50 results for select compounds described in Chapters 2-5 against a range of cancer cell lines. Chapter 9 gives experimental details for processes discussed in Chapters 2-8 and characterisation data for the novel compounds discussed in Chapters 2-5.
author Lucas, Stephanie Jayne
author_facet Lucas, Stephanie Jayne
author_sort Lucas, Stephanie Jayne
title The synthesis of group 9 complexes for use as transfer hydrogenation catalysts and anti-cancer agents
title_short The synthesis of group 9 complexes for use as transfer hydrogenation catalysts and anti-cancer agents
title_full The synthesis of group 9 complexes for use as transfer hydrogenation catalysts and anti-cancer agents
title_fullStr The synthesis of group 9 complexes for use as transfer hydrogenation catalysts and anti-cancer agents
title_full_unstemmed The synthesis of group 9 complexes for use as transfer hydrogenation catalysts and anti-cancer agents
title_sort synthesis of group 9 complexes for use as transfer hydrogenation catalysts and anti-cancer agents
publisher University of Leeds
publishDate 2013
url http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.581646
work_keys_str_mv AT lucasstephaniejayne thesynthesisofgroup9complexesforuseastransferhydrogenationcatalystsandanticanceragents
AT lucasstephaniejayne synthesisofgroup9complexesforuseastransferhydrogenationcatalystsandanticanceragents
_version_ 1718692003829514240